Gastrointestinal Diagnostics Market Report: Market Size & Forecast 2026

The gastrointestinal diagnostics market comprises specialized diagnostic products and technologies used to evaluate conditions affecting the esophagus, stomach, small intestine, and colon. The market includes endoscopy devices, biopsy instruments, stool-based diagnostic assays, breath tests, and imaging systems that support both clinical and laboratory settings. With a 2025 valuation near $5.58 billion, the sector serves hospitals, diagnostic laboratories, ambulatory surgical centers, and increasingly, home-based testing environments.

• •Market valued at approximately $5.58 billion in 2025, with projected growth to $6.56-$7.33 billion by 2030-2031 depending on the forecast model
• •Includes endoscopy devices, biopsy tools, assay kits, imaging technologies, and stool-based diagnostic tests
• •Serves hospitals, ambulatory surgical centers, diagnostic laboratories, and growing at-home testing segments

Rising global incidence of gastrointestinal disorders, including colorectal cancer, inflammatory bowel disease, and gastroesophageal reflux disease, is a primary catalyst for market expansion. An aging demographic and growing adoption of Western dietary patterns have contributed to increased disease burden worldwide. Additionally, technological innovations in non-invasive testing, capsule endoscopy, and molecular diagnostics are enabling earlier detection and broadening the scope of diagnostic capabilities.

• •Rising prevalence of GI disorders such as colorectal cancer and inflammatory bowel disease globally
• •Advancements in molecular diagnostics, artificial intelligence integration, and minimally invasive technologies
• •Growing healthcare spending and increased screening programs for gastrointestinal conditions

The market is typically segmented by product type, including endoscopy devices, biopsy forceps, assay kits and reagents, imaging systems, and patient monitoring tools. By end user, the market serves hospitals, diagnostic laboratories, ambulatory surgical centers, and research institutions. Geographically, North America commands the largest share due to advanced healthcare infrastructure and high disease awareness, while the Asia-Pacific region is expected to register the fastest growth driven by rising healthcare access and improving diagnostic capabilities.

• •North America holds the largest market share, supported by advanced healthcare infrastructure and high disease awareness
• •Asia-Pacific is projected as the fastest-growing region due to expanding healthcare access and rising screening adoption
• •Key product segments include endoscopy devices, biopsy instruments, immunoassay kits, and imaging technologies

What are the recent trends and outlook?

The integration of artificial intelligence and machine learning into endoscopic image analysis is an emerging trend expected to improve diagnostic accuracy and workflow efficiency. Growing preference for non-invasive or minimally invasive procedures, including capsule endoscopy and liquid biopsy, is reshaping product development priorities. The market is also seeing increased investment in point-of-care testing solutions and at-home stool-based screening kits, particularly for colorectal cancer detection. Over the 2025-2030 period, the sector is well-positioned for sustained, above-average growth within the broader medical diagnostics industry.

• •AI and machine learning integration into endoscopy and diagnostic imaging is enhancing early detection capabilities
• •Rising adoption of capsule endoscopy, virtual colonoscopy, and liquid biopsy for minimally invasive screening
• •Expansion of at-home and point-of-care GI testing, particularly for colorectal cancer, is opening new distribution channels